This award recognizes an individual that has made significant contributions to CARRA and consistently demonstrates a high degree of excellence in teamwork and collaboration. This individual demonstrates generosity and willingness to assist others in the CARRA community.

Eligibility

• Individual must be a CARRA member or member of the CARRA community.
• If the individual is a CARRA member, he/she/they must be a member a member in good standing.
• An individual may only receive this award once. Previous Outstanding Service Award honorees are not eligible.

Nomination Process

• Nominations will be accepted from any CARRA member in good standing or by CARRA staff.
• Nominations must include a nomination letter that details what makes the nominee exceptional. Specific examples of service and impact should be provided along with how the nominee fits within the award characteristics.
• An additional letter the support will be required regarding the nominee’s impact and service.
• Include the nominee’s CV. If CV is not included in the submission packet, one will be requested from the nominee.
• Application Materials are due Monday January 22, 2025.

Selection Criteria

Nominees for this award should have made selfless contribution to the organization and demonstrated impact as follows:

• This individual’s work has advanced CARRA’s goals in measurable ways.
• Encourages others to conduct work in ways that will advance the goals of CARRA, and advance the careers of CARRA members.
• This individual might be someone who works behind the scenes “unsung hero” to support other CARRA members and CARRA work.

This award recognizes an early career investigator who has demonstrated research excellence, potential to be a future leader, and passion and commitment to the field of pediatric rheumatology.

Eligibility

• Individual must be junior faculty (up to 7 years after graduating from clinical or post-doctoral fellowship) and a CARRA member in good standing. Current fellows are not eligible.
• An individual may only receive this award once. Previous Early Investigator Award honorees are not eligible.

Nomination Process

• Nominations will be accepted from any CARRA member in good standing or by CARRA staff.
• Nominations must include a nomination letter that details how the individual exemplifies dedication to pediatric rheumatology research and scientific excellence.
• An additional letter of support will be required regarding the nominee’s engagement and impact within CARRA.
• Include the nominee’s CV. If CV is not included in the submission packet, one will be requested from the nominee.
• Application Materials are due Monday January 22, 2025.

Selection Criteria

• Conducts original research in basic, clinical, or translational science to advance pediatric rheumatology.
• Demonstrated academic productivity.
• Innovation in their research or research approach.
• Engagement with and/or support of CARRA scientific priorities.

This award is intended to recognize a CARRA Registry coordinator who has 1) enhanced engagement between the site’s clinical care and research team with the CARRA Registry, and 2) made exceptional contributions to his/her site’s CARRA Registry performance.

Eligibility

• Individual must be a current CARRA Registry coordinator and CARRA Member in good standing.
• Outstanding Research Coordinator Award awardees from the past 3 years (2024, 2023, 2022) are not eligible.
• Coordinators who received previous “Honorable Mention” acknowledgements, but were not selected as a primary awardee, are eligible.

Nomination Process

• Nominations will be accepted from staff at DCRI based on criteria described below
• Once nominations are received, CARRA Staff will contact the site PI to second the nomination and request nomination materials.
• The nomination materials from the Site PI should include a letter of support. This letter of support should detail: 1) How the individual fosters a positive environment to support CARRA and the CARRA Registry at his/her site. 2) What makes the nominee exceptional. 3) How the nominee has engaged his/her site’s clinical care team to enhance performance on the CARRA Registry.
• Nomination Materials from the Site PI are due by Monday, January 22, 2025, and will be submitted to CARRA for review and selection of awardee.

Selection Criteria

Nominees for this award should have made contributions to the Registry site and to CARRA and demonstrated impact and engagement as follows:

• The individual’s work has advanced the site’s CARRA Registry performance in measurable ways.
• The individual encourages others to conduct work in ways that will advance the goals of/performance on the CARRA Registry.
• Exceptional or improved CARRA Registry site performance such as regular enrollment, high data quality, and assisting with engaging site’s pediatric rheumatology care team to support the CARRA Registry.
• The individual demonstrates high responsiveness regarding Registry task completion, regulatory compliance and regular correspondence with DCRI.

This award recognizes a CARRA workgroup leader who has demonstrated successful engagement of workgroup members and sustained commitment to advancing the mission of CARRA and the activities of his/her workgroup.

Eligibility

• Individual must be a current CARRA workgroup leader and a member in good standing.
• Outstanding Workgroup Leader Award honorees from the past 3 years (2023, 2022, 2021) are not eligible, unless the individual is being nominated for leadership of a different workgroup.

Nomination Process

• Nominations will be accepted from any CARRA member in good standing or by CARRA staff.
• Nominations must include a nomination letter that details what makes the nominee exceptional. Specific examples of service and impact should be provided along with how the nominee fits within the award characteristics.
• An additional supporting letter from a second workgroup member or committee leader will be required regarding the nominee’s impact and service.
• Include the nominee’s CV. If CV is not included in the submission packet, one will be requested from the nominee.
• Application Materials are due Monday January 22, 2025.

Selection Criteria

Nominees for this award should have made significant contributions to CARRA and their workgroup, demonstrating excellence in at least one of the following areas:

• Productivity: has led workgroup to accomplish steady and/or significant progress during tenure as workgroup leader.
• Inclusiveness: has engaged and effectively leveraged the expertise of members with diverse backgrounds and experience (including established and early investigators, trainees, coordinators and other non-physician members, patients and families).
• Innovation: has implemented innovative strategies to improve workgroup productivity and/or engagement.

This award recognizes outstanding contributions to CARRA by a caregiver or patient. The awardee demonstrates commitment to CARRA’s research through meaningful participation in CARRA related activities, leadership, and a willingness to engage with members, workgroups, or committees.

Eligibility

• Individual must be a caregiver or a patient diagnosed with a pediatric rheumatic disease.
• CARRA staff are not eligible.
• Honorees from the past 3 years (2023, 2022, 2021) are not eligible.

Nomination Process

• Nominations will be accepted from CARRA staff or any CARRA member in good standing.
• Nominations must include a nomination letter that details the exceptional contributions the nominee has made to CARRA.
• Application Materials are due Monday January 22, 2025.

Selection Criteria

Nominees for this award have made contributions to CARRA and demonstrated impact by one or more of the following:

• This individual has made meaningful contributions to enhance patient engagement in CARRA through specific projects, workgroups, committees, grant review, or other CARRA activities.
• Displays a willingness to advance CARRA through their attendance, participation, and responsiveness.
• Assumes a leadership role and/or is responsible for deliverables.
• Raises awareness of CARRA and CARRA activities in their community.
• Engages additional patients/caregivers in CARRA’s work.